Alpha Teknova produces high-quality reagents and culture media such as pre-poured agar plates, liquid microbial media, buffers, and molecular biology tools for use in biotechnology research and manufacturing. These products support cell and gene therapy development, vaccine production, diagnostics, and general life sciences workflows in laboratories and bioprocessing facilities. The company supplies both catalog items and custom formulations to pharmaceutical, biotech, and academic customers.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 10.3 | — | -3.6 | — |
| Q3 2025 | 10.4 | — | -4.3 | — |
| Q4 2025 | 10 | — | -4.8 | — |
| Q1 2026 | 11.1 | — | -4.5 | — |
| Q2 2026 | 12.2 | 18.4% | -3.2 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: MVB Financial Corp. (MVBF), Yorkville International Capital Corp. (YICC), New Era Energy & Digital, Inc. (NUAI), Aldabra 4 Liquidity Opportunity Vehicle, Inc. (ALOV), Bleichroeder Acquisition Corp II (BBCQ), Rimini Street, Inc. (RMNI)